$ULBI
ULTRALIFE CORP

2021 Q4 Form 10-Q Financial Statement

#000143774921024454 Filed on October 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $23.76M $21.76M $24.36M
YoY Change -18.0% -10.68% -11.39%
Cost Of Revenue $18.47M $16.65M $17.85M
YoY Change -14.59% -6.71% -9.07%
Gross Profit $5.289M $5.108M $6.511M
YoY Change -28.04% -21.55% -17.17%
Gross Profit Margin 22.26% 23.47% 26.73%
Selling, General & Admin $4.765M $4.164M $4.198M
YoY Change 5.89% -0.81% -7.25%
% of Gross Profit 90.09% 81.52% 64.48%
Research & Development $1.578M $1.723M $1.606M
YoY Change 5.91% 7.29% -20.85%
% of Gross Profit 29.84% 33.73% 24.67%
Depreciation & Amortization $921.0K $700.0K $582.0K
YoY Change 21.18% 20.27% -0.68%
% of Gross Profit 17.41% 13.7% 8.94%
Operating Expenses $6.518M $5.887M $5.804M
YoY Change 6.33% 1.43% -11.46%
Operating Profit -$1.229M -$779.0K $707.0K
YoY Change -200.74% -210.18% -45.87%
Interest Expense -$78.00K -$53.00K -$90.00K
YoY Change 30.0% -41.11% -59.09%
% of Operating Profit -12.73%
Other Income/Expense, Net -$32.00K $1.000K -$53.00K
YoY Change -153.33% -101.89% -66.88%
Pretax Income -$1.339M -$778.0K $654.0K
YoY Change -147.82% -218.96% -42.93%
Income Tax -$211.0K -$175.0K $192.0K
% Of Pretax Income 29.36%
Net Earnings -$1.131M -$585.0K $407.0K
YoY Change -153.6% -243.73% -54.68%
Net Earnings / Revenue -4.76% -2.69% 1.67%
Basic Earnings Per Share -$4.00 $3.00
Diluted Earnings Per Share -$70.30K -$4.00 $3.00
COMMON SHARES
Basic Shares Outstanding 16.08M 16.07M 15.91M
Diluted Shares Outstanding 16.07M 16.09M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.413M $15.85M $13.80M
YoY Change -21.37% 14.88% 94.37%
Cash & Equivalents $8.329M $15.77M $13.69M
Short-Term Investments
Other Short-Term Assets $4.690M $4.271M $3.700M
YoY Change 1.96% 15.43% 27.59%
Inventory $33.19M $28.18M $29.75M
Prepaid Expenses
Receivables $20.23M $16.24M $15.01M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $66.52M $64.54M $62.20M
YoY Change 3.14% 3.77% -9.87%
LONG-TERM ASSETS
Property, Plant & Equipment $23.21M $23.04M $22.61M
YoY Change 1.55% 1.9% 0.03%
Goodwill $38.07M $27.00M $26.71M
YoY Change 40.9% 1.1% 1.26%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.879M $1.816M $2.411M
YoY Change 25.61% -24.68% 15.58%
Total Long-Term Assets $93.01M $72.27M $73.36M
YoY Change 27.06% -1.48% -1.26%
TOTAL ASSETS
Total Short-Term Assets $66.52M $64.54M $62.20M
Total Long-Term Assets $93.01M $72.27M $73.36M
Total Assets $159.5M $136.8M $135.6M
YoY Change 15.86% 0.93% -5.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.823M $9.206M $8.875M
YoY Change -9.37% 3.73% -15.08%
Accrued Expenses $7.101M $7.229M $7.000M
YoY Change 9.25% 3.27% 7.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $253.0K $1.537M
YoY Change 46.95% -83.54% 15.91%
Total Short-Term Liabilities $18.92M $16.69M $17.37M
YoY Change 1.17% -3.94% -4.93%
LONG-TERM LIABILITIES
Long-Term Debt $18.86M $0.00 $2.190M
YoY Change -100.0% -86.53%
Other Long-Term Liabilities $1.760M $1.103M $1.675M
YoY Change 13.04% -34.15% 18.04%
Total Long-Term Liabilities $20.62M $1.103M $3.865M
YoY Change 1224.15% -71.46% -78.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.92M $16.69M $17.37M
Total Long-Term Liabilities $20.62M $1.103M $3.865M
Total Liabilities $41.80M $18.27M $21.72M
YoY Change 101.15% -15.89% -40.42%
SHAREHOLDERS EQUITY
Retained Earnings -$47.83M -$46.70M -$49.71M
YoY Change 0.49% -6.05% -8.72%
Common Stock $2.052M $2.051M $2.033M
YoY Change 0.74% 0.89% 0.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $21.47M $21.47M $21.25M
YoY Change 0.69% 1.05% 0.07%
Treasury Stock Shares $4.433M $4.433M $4.403M
Shareholders Equity $117.6M $118.4M $113.7M
YoY Change
Total Liabilities & Shareholders Equity $159.5M $136.8M $135.6M
YoY Change 15.86% 0.93% -5.41%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$1.131M -$585.0K $407.0K
YoY Change -153.6% -243.73% -54.68%
Depreciation, Depletion And Amortization $921.0K $700.0K $582.0K
YoY Change 21.18% 20.27% -0.68%
Cash From Operating Activities -$4.137M $1.507M $12.61M
YoY Change -1898.7% -88.05% -2201.67%
INVESTING ACTIVITIES
Capital Expenditures -$490.0K -$1.099M -$370.0K
YoY Change -59.17% 197.03% -65.09%
Acquisitions
YoY Change
Other Investing Activities -$23.52M $0.00 $0.00
YoY Change
Cash From Investing Activities -$24.01M -$1.099M -$370.0K
YoY Change 1900.75% 197.03% -64.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.58M -394.0K -6.910M
YoY Change -946.83% -94.3% -418.43%
NET CHANGE
Cash From Operating Activities -4.137M 1.507M 12.61M
Cash From Investing Activities -24.01M -1.099M -370.0K
Cash From Financing Activities 20.58M -394.0K -6.910M
Net Change In Cash -7.568M 14.00K 5.330M
YoY Change 122.59% -99.74% 925.0%
FREE CASH FLOW
Cash From Operating Activities -$4.137M $1.507M $12.61M
Capital Expenditures -$490.0K -$1.099M -$370.0K
Free Cash Flow -$3.647M $2.606M $12.98M
YoY Change -355.03% -79.92% 2721.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16080749
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
334000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
317000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
8725000 USD
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1377000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8462000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2324000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2324000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000 USD
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
9209000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11700000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11836000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1816000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2292000 USD
CY2021Q3 us-gaap Assets
Assets
136812000 USD
CY2020Q4 us-gaap Assets
Assets
137701000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9206000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10839000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
253000 USD
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20513344
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20373519
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16080749
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15959984
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4432595
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4413535
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4814000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-775000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q3 us-gaap Cash
Cash
15853000 USD
CY2020Q4 us-gaap Cash
Cash
10653000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16235000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21054000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
28179000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
28193000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4271000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4596000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
64538000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
64496000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23035000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22850000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
26998000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
27018000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1361000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1153000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1748000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6076000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4758000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16688000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18706000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
475000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
515000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1103000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1557000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
18266000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
20778000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2051000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2037000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186360000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
185464000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46701000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47598000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1819000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1782000 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
21469000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
21321000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
118422000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
116800000 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
124000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
123000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
118546000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116923000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136812000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
137701000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21761000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24362000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74504000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
78736000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
16653000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
17851000 USD
us-gaap Cost Of Revenue
CostOfRevenue
55151000 USD
us-gaap Cost Of Revenue
CostOfRevenue
56928000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
5108000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
6511000 USD
us-gaap Gross Profit
GrossProfit
19353000 USD
us-gaap Gross Profit
GrossProfit
21808000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1723000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1606000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5223000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4429000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4164000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4198000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12866000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12893000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5887000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
5804000 USD
us-gaap Operating Expenses
OperatingExpenses
18089000 USD
us-gaap Operating Expenses
OperatingExpenses
17322000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-779000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
707000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1264000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4486000 USD
CY2021Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
53000 USD
CY2020Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
92000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
164000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
372000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
54000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
88000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
110000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-262000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-778000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
654000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1188000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4224000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-175000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
290000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1010000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-603000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
462000 USD
us-gaap Profit Loss
ProfitLoss
898000 USD
us-gaap Profit Loss
ProfitLoss
3214000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
55000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
90000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-585000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
407000 USD
us-gaap Net Income Loss
NetIncomeLoss
897000 USD
us-gaap Net Income Loss
NetIncomeLoss
3124000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-233000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
677000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-88000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-818000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1084000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
860000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3036000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
20
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
19
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16065000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15908000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16020000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15889000
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
181000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
180000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
214000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16065000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
444000 USD
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16089000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16200000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16103000
us-gaap Profit Loss
ProfitLoss
898000 USD
us-gaap Profit Loss
ProfitLoss
3214000 USD
us-gaap Depreciation
Depreciation
2160000 USD
us-gaap Depreciation
Depreciation
1743000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
458000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
78000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
148000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
218000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
512000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
756000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-127000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-821000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15094000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
84000 USD
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-546000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21491000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1902000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
120000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1782000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1186000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
13461000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
398000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-936000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13258000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-79000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6372000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10653000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7405000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15853000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13777000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109750000 USD
us-gaap Profit Loss
ProfitLoss
3214000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
218000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
674000 USD
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
82000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-13000 USD
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-88000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
113837000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116923000 USD
us-gaap Profit Loss
ProfitLoss
898000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
265000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
468000 USD
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
44000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15000 USD
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-37000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
118546000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
112334000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
462000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
142000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
204000 USD
CY2020Q3 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
18000 USD
CY2020Q3 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
677000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
113837000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
119237000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-603000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
131000 USD
CY2021Q3 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
11000 USD
CY2021Q3 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-233000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
118546000 USD
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
831244
CY2020Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
19165
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
181270
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
598489
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
14164
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
179951
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
831244
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
19165
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
213574
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15766000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10562000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
87000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
91000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15853000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10653000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16955000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17277000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3485000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3411000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7739000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7505000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
28179000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
28193000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90422000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88070000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67387000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
65220000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23035000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22850000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
700000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
582000 USD
us-gaap Depreciation
Depreciation
2160000 USD
us-gaap Depreciation
Depreciation
1743000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
27018000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-20000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
26998000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19983000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11258000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8725000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20039000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10830000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9209000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.50
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
184429
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
148000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
149000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
458000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
444000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
142000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
222000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
512000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
756000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1217163
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.50
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
24578
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.35
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1064656
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M29D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
978000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
995875
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y8M15D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
958000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
769123
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.77
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y1M20D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
889000 USD
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
84000 USD
CY2020Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
142000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
398000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
218000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239 pure
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
188000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
172000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
564000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
508000 USD
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
25000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
18000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
57000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
54000 USD
CY2021Q3 us-gaap Lease Cost
LeaseCost
213000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
190000 USD
us-gaap Lease Cost
LeaseCost
621000 USD
us-gaap Lease Cost
LeaseCost
562000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
550000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
506000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
875000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
179000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
700000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1878000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
135000 USD
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
1100000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
720000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
279000 USD
us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
75000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
143000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
103000 USD
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
129000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
167000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
149000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
195000 USD
us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
123000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21761000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-779000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-175000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-585000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24362000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
707000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
55000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
407000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74504000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1264000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
290000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000 USD
us-gaap Net Income Loss
NetIncomeLoss
897000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
78736000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4486000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-262000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1010000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
90000 USD
us-gaap Net Income Loss
NetIncomeLoss
3124000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21761000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24362000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74504000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
78736000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21761000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24362000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74504000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
78736000 USD

Files In Submission

Name View Source Status
0001437749-21-024454-index-headers.html Edgar Link pending
0001437749-21-024454-index.html Edgar Link pending
0001437749-21-024454.txt Edgar Link pending
0001437749-21-024454-xbrl.zip Edgar Link pending
ex_294723.htm Edgar Link pending
ex_294724.htm Edgar Link pending
ex_294725.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20210930.xsd Edgar Link pending
ulbi-20210930_cal.xml Edgar Link unprocessable
ulbi-20210930_def.xml Edgar Link unprocessable
ulbi-20210930_lab.xml Edgar Link unprocessable
ulbi-20210930_pre.xml Edgar Link unprocessable
ulbi20210930_10q.htm Edgar Link pending
ulbi20210930_10q_htm.xml Edgar Link completed